In the latest episode of the BioProcess Insider Expression Platform, Thermo Fisher Scientific’s Vincenza Pironti discusses how vaccine and biologic makers can ensure a robust, global fill/finish supply both during the COVID pandemic and beyond.

Vincenza Pironti – Global SME, Steriles, ThermoFisher Scientific – sat down (at a distance) with editor Dan Stanton to discuss aseptic manufacturing in the current climate as part of this year’s BIO-Europe Spring.

The event took place last week, but if you missed it the conversation has been captured in the latest epsiode in our podcast series.

Listen below, Google, ITunes, or wherever you get your podcasts.